Jan J Cornelissen Selected Research

Cord Blood Stem Cell Transplantation

10/2022	Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
1/2018	Impaired thymopoiesis predicts for a high risk of severe infections after reduced intensity conditioning without anti-thymocyte globulin in double umbilical cord blood transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan J Cornelissen Research Topics

Disease

47	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 01/2005
43	Leukemia 03/2024 - 10/2003
22	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2023 - 10/2003
21	Neoplasms (Cancer) 05/2024 - 05/2005
17	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2024 - 02/2009
12	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2023 - 03/2003
11	Infections 01/2023 - 08/2005
9	Multiple Myeloma 01/2022 - 03/2003
6	Bronchiolitis Obliterans Syndrome 11/2021 - 01/2018
5	Lymphoma (Lymphomas) 01/2023 - 10/2003
5	Aspergillosis 01/2023 - 07/2015
4	Primary Myelofibrosis (Myelosclerosis) 10/2021 - 01/2019
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 06/2002
4	Philadelphia Chromosome 01/2019 - 03/2003
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 01/2018
3	Residual Neoplasm 11/2017 - 01/2016
3	Neutropenia 07/2015 - 05/2003
3	Invasive Pulmonary Aspergillosis 07/2015 - 05/2003
2	Plasma Cell Leukemia 01/2023 - 01/2016
2	Hepatitis E 01/2019 - 08/2013
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 11/2014
2	Pathologic Complete Response 09/2012 - 12/2011
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2010 - 08/2008
2	Blast Crisis (Blast Phase) 12/2006 - 03/2003
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Persistent Infection 01/2022
1	Discitis 02/2020
1	Mucormycosis 02/2020
1	Refractory Anemia 01/2020
1	Polycythemia Vera 01/2019
1	Essential Thrombocythemia 01/2019
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2019
1	monosomy Chromosome 7 01/2018
1	Monosomy 01/2018
1	Prolymphocytic Leukemia 08/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2015
1	Chemical and Drug Induced Liver Injury 08/2014

Drug/Important Bio-Agent (IBA)

11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2023 - 03/2003
6	Tyrosine Kinase InhibitorsIBA 01/2022 - 03/2015
6	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021 - 01/2016
6	Imatinib Mesylate (Gleevec)FDA Link 08/2013 - 03/2003
5	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2013 - 03/2003
3	Clofarabine (Clolar)FDA Link 05/2024 - 01/2022
3	AzolesIBA 01/2023 - 09/2018
3	liposomal amphotericin B FDA Link 02/2020 - 05/2008
2	fludarabineIBA 01/2023 - 08/2015
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
2	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 01/2019
2	Voriconazole (Vfend)FDA LinkGeneric 02/2020 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 03/2019 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2010
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2015 - 03/2007
2	EnzymesIBA 08/2014 - 08/2013
2	Fibroblast Growth Factor 7 FDA Link 06/2009 - 12/2007
2	Melphalan (Alkeran)FDA LinkGeneric 07/2007 - 03/2003
2	Interferon-alpha (Interferon Alfa)IBA 12/2006 - 03/2003
2	bcr-abl Fusion ProteinsIBA 12/2006 - 03/2003
1	Phosphotransferases (Kinase)IBA 12/2023
1	asciminibIBA 01/2023
1	monalizumabIBA 01/2023
1	HLA-E AntigensIBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	TriazolesIBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	fms-Like Tyrosine Kinase 3IBA 01/2022
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2022
1	NucleosidesIBA 01/2022
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022
1	Neutralizing AntibodiesIBA 11/2021
1	Viral RNAIBA 11/2021
1	posaconazole FDA Link 02/2020
1	IA 4IBA 02/2020
1	Decitabine FDA Link 01/2020
1	PanobinostatIBA 01/2020
1	Core Binding Factors (Core-Binding Factor)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019
1	Asparaginase (Elspar)FDA Link 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Etanercept (Enbrel)FDA Link 01/2017
1	SteroidsIBA 01/2017

Therapy/Procedure

62	Transplantation 05/2024 - 06/2002
47	Stem Cell Transplantation 12/2023 - 06/2002
34	Hematopoietic Stem Cell Transplantation 03/2024 - 01/2005
20	Therapeutics 04/2023 - 03/2003
14	Cell Transplantation 04/2023 - 08/2007
8	Drug Therapy (Chemotherapy) 01/2020 - 03/2003
6	Homologous Transplantation 01/2018 - 10/2003
4	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2021 - 12/2011
2	Cord Blood Stem Cell Transplantation 10/2022 - 01/2018
2	Consolidation Chemotherapy 03/2014 - 12/2011
2	Chemoradiotherapy 11/2008 - 10/2003
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2007 - 08/2005
1	Precision Medicine 01/2023
1	Salvage Therapy 02/2020
1	Haploidentical Transplantation 01/2019
1	Withholding Treatment 11/2017
1	Induction Chemotherapy 01/2016